A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer

Sanoj Punnen, Janet E. Cowan, Laura B. Dunn, Dianne M. Shumay, Peter R. Carroll, Matthew R. Cooperberg

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Objective To evaluate the prevalence of depression, anxiety and distress among active surveillance (AS) and radical prostatectomy (RP) patients. To evaluate the impact of these symptoms at baseline on urinary and sexual quality of life at follow-up. Patients and Methods Patients managed with AS or RP who completed validated questionnaires assessing levels of depression, anxiety, distress and urinary (UF) and sexual function (SF) and bother comprised the final analytic cohort. These measures were completed at baseline, within 1 year, and between 1 and 3 years from baseline. Mixed model repeated measures analysis was used to examine associations between mental health at baseline and sexual and urinary outcomes in a subset of RP patients with complete follow-up. Results Among 679 men who comprised the study cohort, baseline prevalence of moderate or higher levels of depression or anxiety were low (<5%), while levels of mild depression or anxiety ranged from 3-16% over time. Baseline levels of elevated distress ranged from 8-20%. Among men who provided data at baseline and follow-up, there were no significant differences between AS and RP patients in the proportion of men with elevated levels of depression, anxiety, or distress. Among 177 men who underwent RP and had complete follow-up moderate or higher levels of depression or anxiety appeared to be associated with post-treatment SF and bother, while elevated levels of distress were associated with post-treatment UF. Conclusion Moderate or higher levels of depression or anxiety were low in men with localised prostate cancer but were associated with sexual outcomes, while elevated distress was associated with urinary outcomes. Greater attention should be paid to mental health symptoms among men with prostate cancer, as these symptoms may be associated with quality of life outcomes.

Original languageEnglish (US)
JournalBJU International
Volume112
Issue number2
DOIs
StatePublished - Jul 2013
Externally publishedYes

Fingerprint

Longitudinal Studies
Prostatic Neoplasms
Anxiety
Prostatectomy
Quality of Life
Depression
Mental Health Associations
Mental Health
Cohort Studies
Therapeutics

Keywords

  • active surveillance
  • mental health
  • prostate cancer
  • radical prostatectomy

ASJC Scopus subject areas

  • Urology

Cite this

A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer. / Punnen, Sanoj; Cowan, Janet E.; Dunn, Laura B.; Shumay, Dianne M.; Carroll, Peter R.; Cooperberg, Matthew R.

In: BJU International, Vol. 112, No. 2, 07.2013.

Research output: Contribution to journalArticle

Punnen, Sanoj ; Cowan, Janet E. ; Dunn, Laura B. ; Shumay, Dianne M. ; Carroll, Peter R. ; Cooperberg, Matthew R. / A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer. In: BJU International. 2013 ; Vol. 112, No. 2.
@article{77f2c772e6b8447587074bc59f3164b1,
title = "A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer",
abstract = "Objective To evaluate the prevalence of depression, anxiety and distress among active surveillance (AS) and radical prostatectomy (RP) patients. To evaluate the impact of these symptoms at baseline on urinary and sexual quality of life at follow-up. Patients and Methods Patients managed with AS or RP who completed validated questionnaires assessing levels of depression, anxiety, distress and urinary (UF) and sexual function (SF) and bother comprised the final analytic cohort. These measures were completed at baseline, within 1 year, and between 1 and 3 years from baseline. Mixed model repeated measures analysis was used to examine associations between mental health at baseline and sexual and urinary outcomes in a subset of RP patients with complete follow-up. Results Among 679 men who comprised the study cohort, baseline prevalence of moderate or higher levels of depression or anxiety were low (<5{\%}), while levels of mild depression or anxiety ranged from 3-16{\%} over time. Baseline levels of elevated distress ranged from 8-20{\%}. Among men who provided data at baseline and follow-up, there were no significant differences between AS and RP patients in the proportion of men with elevated levels of depression, anxiety, or distress. Among 177 men who underwent RP and had complete follow-up moderate or higher levels of depression or anxiety appeared to be associated with post-treatment SF and bother, while elevated levels of distress were associated with post-treatment UF. Conclusion Moderate or higher levels of depression or anxiety were low in men with localised prostate cancer but were associated with sexual outcomes, while elevated distress was associated with urinary outcomes. Greater attention should be paid to mental health symptoms among men with prostate cancer, as these symptoms may be associated with quality of life outcomes.",
keywords = "active surveillance, mental health, prostate cancer, radical prostatectomy",
author = "Sanoj Punnen and Cowan, {Janet E.} and Dunn, {Laura B.} and Shumay, {Dianne M.} and Carroll, {Peter R.} and Cooperberg, {Matthew R.}",
year = "2013",
month = "7",
doi = "10.1111/bju.12209",
language = "English (US)",
volume = "112",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer

AU - Punnen, Sanoj

AU - Cowan, Janet E.

AU - Dunn, Laura B.

AU - Shumay, Dianne M.

AU - Carroll, Peter R.

AU - Cooperberg, Matthew R.

PY - 2013/7

Y1 - 2013/7

N2 - Objective To evaluate the prevalence of depression, anxiety and distress among active surveillance (AS) and radical prostatectomy (RP) patients. To evaluate the impact of these symptoms at baseline on urinary and sexual quality of life at follow-up. Patients and Methods Patients managed with AS or RP who completed validated questionnaires assessing levels of depression, anxiety, distress and urinary (UF) and sexual function (SF) and bother comprised the final analytic cohort. These measures were completed at baseline, within 1 year, and between 1 and 3 years from baseline. Mixed model repeated measures analysis was used to examine associations between mental health at baseline and sexual and urinary outcomes in a subset of RP patients with complete follow-up. Results Among 679 men who comprised the study cohort, baseline prevalence of moderate or higher levels of depression or anxiety were low (<5%), while levels of mild depression or anxiety ranged from 3-16% over time. Baseline levels of elevated distress ranged from 8-20%. Among men who provided data at baseline and follow-up, there were no significant differences between AS and RP patients in the proportion of men with elevated levels of depression, anxiety, or distress. Among 177 men who underwent RP and had complete follow-up moderate or higher levels of depression or anxiety appeared to be associated with post-treatment SF and bother, while elevated levels of distress were associated with post-treatment UF. Conclusion Moderate or higher levels of depression or anxiety were low in men with localised prostate cancer but were associated with sexual outcomes, while elevated distress was associated with urinary outcomes. Greater attention should be paid to mental health symptoms among men with prostate cancer, as these symptoms may be associated with quality of life outcomes.

AB - Objective To evaluate the prevalence of depression, anxiety and distress among active surveillance (AS) and radical prostatectomy (RP) patients. To evaluate the impact of these symptoms at baseline on urinary and sexual quality of life at follow-up. Patients and Methods Patients managed with AS or RP who completed validated questionnaires assessing levels of depression, anxiety, distress and urinary (UF) and sexual function (SF) and bother comprised the final analytic cohort. These measures were completed at baseline, within 1 year, and between 1 and 3 years from baseline. Mixed model repeated measures analysis was used to examine associations between mental health at baseline and sexual and urinary outcomes in a subset of RP patients with complete follow-up. Results Among 679 men who comprised the study cohort, baseline prevalence of moderate or higher levels of depression or anxiety were low (<5%), while levels of mild depression or anxiety ranged from 3-16% over time. Baseline levels of elevated distress ranged from 8-20%. Among men who provided data at baseline and follow-up, there were no significant differences between AS and RP patients in the proportion of men with elevated levels of depression, anxiety, or distress. Among 177 men who underwent RP and had complete follow-up moderate or higher levels of depression or anxiety appeared to be associated with post-treatment SF and bother, while elevated levels of distress were associated with post-treatment UF. Conclusion Moderate or higher levels of depression or anxiety were low in men with localised prostate cancer but were associated with sexual outcomes, while elevated distress was associated with urinary outcomes. Greater attention should be paid to mental health symptoms among men with prostate cancer, as these symptoms may be associated with quality of life outcomes.

KW - active surveillance

KW - mental health

KW - prostate cancer

KW - radical prostatectomy

UR - http://www.scopus.com/inward/record.url?scp=84879649663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879649663&partnerID=8YFLogxK

U2 - 10.1111/bju.12209

DO - 10.1111/bju.12209

M3 - Article

C2 - 23795800

AN - SCOPUS:84879649663

VL - 112

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 2

ER -